[1]
M. Anand, G. K. Randhawa, and S. K. Salwan, “A prospective, randomised, open label study to compare efficacy and safety of hydroxychloroquine and teneligliptin in patients of type 2 diabetes mellitus refractory to concomitant metformin and glimepiride”, Int J Basic Clin Pharmacol, vol. 12, no. 2, pp. 192–198, Feb. 2023.